CB1 cannabinoid receptor-mediated cell migration

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 1, 2000, Pages 204-209

  Song, Zhao Hui ^a   Zhong, Miao ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 8 BROMO CYCLIC AMP; ADENYLATE KINASE; ANANDAMIDE; CANNABINOID RECEPTOR; DEXANABINOL; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; RIMONABANT;

ARTICLE; CELL MIGRATION; CHEMOKINESIS; CHEMOTAXIS; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENYLATE CYCLASE TOXIN; ARACHIDONIC ACIDS; CELL MOVEMENT; CELLS, CULTURED; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NAPHTHALENES; PERTUSSIS TOXIN; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL; VIRULENCE FACTORS, BORDETELLA;

EID: 0033945650     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR (1995) PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. i-coupled receptors. Proc Natl Acad Sci USA 94:14495-14499.
3. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G and Casellas P (1995) Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641
4. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G and Casellas P (1993) Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214:173-180.
5. Compton DR, Gold LH, Ward SJ, Balster RL and Martin BR (1992) Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta-9-tetrahydro-cannabinol. J Pharmacol Exp Ther 263:1118-1126.
6. Crespo P, Xu N, Simonds WF and Gutkind JS (1994) Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature (Lond) 369:418-420.
7. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
8. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
9. Falk W, Goodwin RH Jr and Leonard EJ (1980) A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239-247.
10. Felder CC, Veluz JS, Williams HL, Briley EM and Matsuda LA (1992) Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42:838-845.
11. Gerard CM, Mollereau C, Vassart G and Parmentier M (1991) Molecular cloning of a human brain cannabinoid receptor which is also expressed in testis. Biochem J 279:129-134.
12. Gerard G and Gerard NP (1996) The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr Opin Immunol 6:140-145.
13. i proteins use a novel βγ- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes. J Biol Chem 274:19992-20001.
14. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR and Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
15. Hill CS and Treisman R (1995) Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80:199-211.
16. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307-313.
17. Klemke RL, Cai S, Giannini AL, Gallagher PJ and de Lanerolle P (1997) Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492.
18. Knall C, Worthen GS and Johnson GL (1997) Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 94:3052-3057.
19. ras. Proc Natl Acad Sci USA 91:12706-12710.
20. Kuroki M and O'Flaherty JT (1997) Differential effects of a mitogen-activated protein kinase kinase inhibitor on human neutrophil responses to chemotactic factors. Biochem Biophys Res Commun 232:474-477.
21. Lauffenburger DA and Horwitz AF (1996) Cell migration: A physically integrated molecular process. Cell 84:359-369.
22. Mackie K and Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
23. Matsuda LA, Bonner TI and Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535-550.
24. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond) 346:561-564.
25. Mechoulam R, Feigenbaum JJ, Lander N, Segal M, Jarbe TU, Hiltunen AJ and Consroe P (1988) Enantiomeric cannabinoids: Stereospecificity of psychotropic activity. Experientia 44:762-764.
26. Mitchison TJ and Cramer LP (1996) Actin-based cell motility and cell locomotion. Cell 84:371-379.
27. Munro S, Thomas KL and Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
28. s. Proc Natl Acad Sci USA 94:14489-14494.
29. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Soubrie P, Breliere J-C and Le Fur G (1994) A potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244.
30. Seger R and Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726-735.
31. Song ZH and Bonner TI (1996) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mol Pharmacol 49:891-896.
32. Wartmann M, Campbell D, Subramanian A, Burstein SH and Davis RJ (1995) The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359:133-136.
33. Wilkinson PC (1998) Assays of leukocyte locomotion and chemotaxis. J Immunol Methods 216:139-153.
34. Zigmond SH and Hirsch JG (1973) Leukocyte locomotion and chemotaxis. J Exp Med 137:387-410.